Investor Overview

Investors hero image

Corporate Profile


Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on developing first-in-class gene therapy treatment options for rare, undertreated diseases. Rocket’s multi-platform development approach applies the well-established lentiviral virus, which we refer to as LVV, adeno-associated virus, which we refer to as AAV, gene therapy platforms.

Stock Information

(Common Stock)

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Scroll to Top